EFTA00674918.txt

"From: Sultan Bin Sulayem To: Jeffrey Epstein <[email protected]> Subject: Fwd: FDA Approved a Potent and Pricey Cholesterol lowering drug today Da"

"Matthew Herper , Forbes Staff I cover science and medicine, and believe this is biology's century. Follow on Forbes"

"Steven Nissen, chairman of cardiology at the Cleveland Clinic"

"Troy Brennan, the chief medical officer of CVS Caremark, the giant pharmacy benefits manager"

"Leonard Schleifer, the chief executive and founder of Regeneron"

"Olivier Brandicourt... Chief Executive Officer, Sanofi"

"Regeneron and its marketing partner Sanofi say Praluent... Praluent demonstrates the power of the Sanofi and Regeneron alliance"

"Mark Schoenebaum, Evercore ISI's pharmaceutical analyst"

"Geoffrey Porges, an biotechnology analyst at investment bank Sanford C. Bernstein"

"Sanofi and Regeneron will be hosting a conference call for the financial community on Praluent (alirocumab) Injection for the treatment of high LDL ch"

"Sanofi and Regeneron will be hosting a conference call for the financial community on Praluent (alirocumab) Injection"

"the European Medicine Agency's (EMA's) Committee for Medicinal Products for Human Use (CHMP)"

"CHMP has adopted a positive opinion for the marketing authorization of Praluent, recommending its approval for use in certain adult patients"

"The European Commission (EC) is expected to make a final decision on the Marketing Authorization Application for Praluent in the European Union in Sep"

"Sanofi is listed in Paris (EURONEXT: SAN)"

"and in New York (NYSE: SNY)"